Tirzepatide 20mg
Tirzepatide – 20mg
Research Grade | Lyophilized Peptide
For Laboratory Research Use Only. Not for Human or Veterinary Use.
Tirzepatide is a synthetic peptide analog designed as a dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. Its combined incretin receptor activity makes it a valuable tool in metabolic, endocrinology, and cellular signaling research.
This product is supplied as a high-purity lyophilized peptide powder suitable for in‑vitro and preclinical laboratory applications.
Chemical Information
Compound Name: Tirzepatide Synonyms: Dual GIP/GLP-1 receptor agonist peptide Peptide Class: Synthetic incretin analog
Peptide Length: ~39 amino acids
Molecular Formula: C₂₂₅H₃₄₃N₅₉O₆₈S
Molecular Weight: ~4,883.1 g/mol
CAS Number: 2097012‑57‑5
Purity: ≥99% (HPLC / MS verified)
Appearance: White to off-white lyophilized powder
Solubility: Soluble in Bacteriostatic Water, DMSO and aqueous laboratory buffers
Fill Size: 20 mg per sterile vial
Mechanism & Research Context
Tirzepatide functions as a dual incretin receptor agonist:
GIP receptor activation — potentiates insulin secretion and regulates metabolic pathways
GLP-1 receptor activation — supports glucose-dependent insulinotropic effects, appetite signaling, and energy homeostasis
Its dual-agonist profile is widely studied in preclinical models of diabetes, obesity, and metabolic dysfunction.
Potential Research Applications
In-vitro studies of incretin pathways
Insulin secretion and pancreatic β-cell function assays
Glucose metabolism and energy homeostasis research
Receptor binding and signaling mechanism studies
Preclinical metabolic disorder models
